{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:29:25Z","timestamp":1772166565274,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T00:00:00Z","timestamp":1602028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T00:00:00Z","timestamp":1602028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Shionogi & Co., Ltd."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Integrin \u03b1\n                      <jats:sub>v<\/jats:sub>\n                      \u03b2\n                      <jats:sub>3<\/jats:sub>\n                      , which are expressed by activated hepatic stellate cells in non-alcoholic steatohepatitis (NASH), play an important role in the fibrosis. Recently, we reported that an RGD peptide positron emission tomography (PET) probe is useful as a predictor of hepatic fibrosis. Kinetic analysis of the RGD PET probe has been performed in tumours, but not in hepatic fibrosis. Therefore, we aimed to quantify hepatic integrin \u03b1\n                      <jats:sub>v<\/jats:sub>\n                      \u03b2\n                      <jats:sub>3<\/jats:sub>\n                      in a model of NASH by kinetic analysis using\n                      <jats:sup>18<\/jats:sup>\n                      F-FPP-RGD\n                      <jats:sub>2<\/jats:sub>\n                      , an integrin \u03b1\n                      <jats:sub>v<\/jats:sub>\n                      \u03b2\n                      <jats:sub>3<\/jats:sub>\n                      PET probe.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      <jats:sup>18<\/jats:sup>\n                      F-FPP-RGD\n                      <jats:sub>2<\/jats:sub>\n                      PET\/CT scans were performed in control and NASH rats. Tissue kinetic analyses were performed using a one-tissue, two-compartment (1T2C) and a two-tissue, three-compartment (2T3C) model using an image-derived input function (IDIF) for the left ventricle. We then conducted correlation analysis between standard uptake values (SUVs) or volume of distribution (\n                      <jats:italic>V<\/jats:italic>\n                      <jats:sub>T<\/jats:sub>\n                      ), evaluated using compartment kinetic analysis and integrin \u03b1\n                      <jats:sub>v<\/jats:sub>\n                      or \u03b2\n                      <jats:sub>3<\/jats:sub>\n                      protein expression.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Biochemical and histological evaluation confirmed the development of NASH rats. Integrin \u03b1\n                      <jats:sub>v<\/jats:sub>\n                      \u03b2\n                      <jats:sub>3<\/jats:sub>\n                      protein expression and hepatic SUV were higher in NASH- than normal rats. The hepatic activity of\n                      <jats:sup>18<\/jats:sup>\n                      F-FPP-RGD\n                      <jats:sub>2<\/jats:sub>\n                      peaked rapidly after administration and then gradually decreased, whereas left ventricular activity rapidly disappeared. The 2T3C model was found to be preferable for\n                      <jats:sup>18<\/jats:sup>\n                      F-FPP-RGD\n                      <jats:sub>2<\/jats:sub>\n                      kinetic analysis in the liver. The\n                      <jats:italic>V<\/jats:italic>\n                      <jats:sub>T (IDIF)<\/jats:sub>\n                      for\n                      <jats:sup>18<\/jats:sup>\n                      F-FPP-RGD\n                      <jats:sub>2<\/jats:sub>\n                      , calculated using the 2T3C model, was significantly higher in NASH- than normal rats and correlated strongly with hepatic integrin \u03b1\n                      <jats:sub>v<\/jats:sub>\n                      and \u03b2\n                      <jats:sub>3<\/jats:sub>\n                      protein expression. The strengths of these correlations were similar to those between SUV\n                      <jats:sub>60\u201390\u00a0min<\/jats:sub>\n                      and hepatic integrin \u03b1\n                      <jats:sub>v<\/jats:sub>\n                      or \u03b2\n                      <jats:sub>3<\/jats:sub>\n                      protein expression.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      We have demonstrated that the\n                      <jats:italic>V<\/jats:italic>\n                      <jats:sub>T (IDIF)<\/jats:sub>\n                      of\n                      <jats:sup>18<\/jats:sup>\n                      F-FPP-RGD\n                      <jats:sub>2<\/jats:sub>\n                      , calculated using kinetic modelling, positively correlates with integrin \u03b1\n                      <jats:sub>v<\/jats:sub>\n                      and \u03b2\n                      <jats:sub>3<\/jats:sub>\n                      protein in the liver of NASH rats. These findings suggest that hepatic\n                      <jats:italic>V<\/jats:italic>\n                      <jats:sub>T (IDIF)<\/jats:sub>\n                      provides a quantitative assessment of integrin \u03b1\n                      <jats:sub>v<\/jats:sub>\n                      \u03b2\n                      <jats:sub>3<\/jats:sub>\n                      protein in liver.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13550-020-00704-3","type":"journal-article","created":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T09:03:57Z","timestamp":1602061437000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Quantitative evaluation of hepatic integrin \u03b1v\u03b23 expression by positron emission tomography imaging using 18F-FPP-RGD2 in rats with non-alcoholic steatohepatitis"],"prefix":"10.1186","volume":"10","author":[{"given":"Shuichi","family":"Hiroyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takemi","family":"Rokugawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miwa","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Iimori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ippei","family":"Morita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kae","family":"Fujisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Matsunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eku","family":"Shimosegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohji","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,7]]},"reference":[{"key":"704_CR1","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.cld.2009.07.005","volume":"13","author":"CK Argo","year":"2009","unstructured":"Argo CK, Caldwell SH. Epidemiology and natural history of non-alcoholic steatohepatitis. Clin Liver Dis. 2009;13:511\u201331.","journal-title":"Clin Liver Dis"},{"key":"704_CR2","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1111\/j.1365-2036.2007.03246.x","volume":"25","author":"P Angulo","year":"2007","unstructured":"Angulo P. GI epidemiology: nonalcoholic fatty liver disease. Aliment Pharmacol Ther. 2007;25:883\u20139.","journal-title":"Aliment Pharmacol Ther"},{"key":"704_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gtc.2019.09.007","volume":"49","author":"MD Muthiah","year":"2020","unstructured":"Muthiah MD, Sanyal AJ. Burden of disease due to nonalcoholic fatty liver disease. Gastroenterol Clin N Am. 2020;49:1\u201323.","journal-title":"Gastroenterol Clin N Am"},{"key":"704_CR4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ajg.2017.05.005","volume":"18","author":"MA El Serafy","year":"2017","unstructured":"El Serafy MA, Kassem AM, Omar H, Mahfouz MS, El Said EL, Raziky M. APRI test and hyaluronic acid as non-invasive diagnostic tools for post HCV liver fibrosis: systematic review and meta-analysis. Arab J Gastroenterol. 2017;18:51\u20137.","journal-title":"Arab J Gastroenterol"},{"key":"704_CR5","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1056\/NEJMra011775","volume":"346","author":"P Angulo","year":"2002","unstructured":"Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002;346:1221\u201331.","journal-title":"N Engl J Med"},{"key":"704_CR6","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1155\/2002\/759701","volume":"16","author":"JA Talwalkar","year":"2002","unstructured":"Talwalkar JA. Motion\u2014all patients with NASH need to have a liver biopsy: arguments for the motion. Can J Gastroenterol. 2002;16:718\u201321.","journal-title":"Can J Gastroenterol"},{"key":"704_CR7","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1053\/jhep.2000.16602","volume":"32","author":"JF Cadranel","year":"2000","unstructured":"Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. Hepatology. 2000;32:477\u201381.","journal-title":"Hepatology"},{"key":"704_CR8","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1053\/jhep.2003.09022","volume":"38","author":"P Bedossa","year":"2003","unstructured":"Bedossa P, Darg\u00e8re D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology. 2003;38:1449\u2013577.","journal-title":"Hepatology"},{"key":"704_CR9","doi-asserted-by":"publisher","first-page":"e0199611","DOI":"10.1371\/journal.pone.0199611","volume":"13","author":"VC Obmann","year":"2018","unstructured":"Obmann VC, Mertineit N, Berzigotti A, Marx C, Ebner L, Kreis R, et al. CT predicts liver fibrosis: prospective evaluation of morphology- and attenuation-based quantitative scores in routine portal venous abdominal scans. PLoS ONE. 2018;13:e0199611.","journal-title":"PLoS ONE"},{"key":"704_CR10","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1165\/rcmb.2015-0032TR","volume":"53","author":"Y Zhou","year":"2015","unstructured":"Zhou Y, Chen H, Ambalavanan N, Liu G, Antony VB, Ding Q, et al. Noninvasive imaging of experimental lung fibrosis. Am J Respir Cell MolBiol. 2015;53:8\u201313.","journal-title":"Am J Respir Cell MolBiol"},{"key":"704_CR11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1172\/JCI122132","volume":"29","author":"SB Montesi","year":"2019","unstructured":"Montesi SB, D\u00e9sog\u00e8re P, Fuchs BC, Caravan P. Molecular imaging of fibrosis: recent advances and future directions. J Clin Invest. 2019;29:24\u201333.","journal-title":"J Clin Invest"},{"key":"704_CR12","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.cgh.2014.09.046","volume":"13","author":"S Singh","year":"2015","unstructured":"Singh S, Venkatesh SK, Wang Z, Miller FH, Motosugi U, Low RN, et al. Diagnostic performance of magnetic resonance elastography in staging liver fibrosis: a systematic review and meta-analysis of individual participant data. ClinGastroenterolHepatol. 2015;13:440\u2013451.e6.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"704_CR13","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1002\/hep.29179","volume":"67","author":"E Herrmann","year":"2018","unstructured":"Herrmann E, de L\u00e9dinghen V, Cassinotto C, Chu WCW, Leung VYF, Ferraioli G, et al. Assessment of biopsy-proven liver fibrosis by two-dimensional shear wave elastography: an individual patient data-based meta-analysis. Hepatology. 2018;67:260\u201372.","journal-title":"Hepatology"},{"key":"704_CR14","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1002\/jmri.25550","volume":"45","author":"L Petitclerc","year":"2017","unstructured":"Petitclerc L, Sebastiani G, Gilbert G, Cloutier G, Tang A. Liver fibrosis: review of current imaging and MRI quantification techniques. J Magn Reson Imaging. 2017;45:1276\u201395.","journal-title":"J Magn Reson Imaging"},{"key":"704_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.addr.2017.10.013","volume":"121","author":"M Baues","year":"2017","unstructured":"Baues M, Dasgupta A, Ehling J, Prakash J, Boor P, Tacke F, et al. Fibrosis imaging: current concepts and future directions. Adv Drug Deliv Rev. 2017;121:9\u201326.","journal-title":"Adv Drug Deliv Rev"},{"key":"704_CR16","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.jhep.2017.11.012","volume":"68","author":"D Schuppan","year":"2018","unstructured":"Schuppan D, Surabattula R, Wang XY. Determinants of fibrosis progression and regression in NASH. J Hepatol. 2018;68:238\u201350.","journal-title":"J Hepatol"},{"key":"704_CR17","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","volume":"14","author":"T Tsuchida","year":"2017","unstructured":"Tsuchida T, Friedman SL. Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol. 2017;14:397\u2013411.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"Suppl. 1","key":"704_CR18","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1016\/S0168-8278(02)00429-4","volume":"38","author":"SL Friedman","year":"2003","unstructured":"Friedman SL. Liver fibrosis\u2014from bench to bedside. J Hepatol. 2003;38(Suppl. 1):S38\u201353.","journal-title":"J Hepatol"},{"key":"704_CR19","doi-asserted-by":"publisher","first-page":"6298128","DOI":"10.1155\/2019\/6298128","volume":"2019","author":"SV Hartimath","year":"2019","unstructured":"Hartimath SV, Boominathan R, Soh V, Cheng P, Deng X, Chong YC, et al. Imaging fibrogenesis in a diet-induced model of nonalcoholicsteatohepatitis (NASH). Contrast Media Mol Imaging. 2019;2019:6298128.","journal-title":"Contrast Media Mol Imaging"},{"key":"704_CR20","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13550-018-0394-4","volume":"8","author":"T Rokugawa","year":"2018","unstructured":"Rokugawa T, Konishi H, Ito M, Iimori H, Nagai R, Shimosegawa E, et al. Evaluation of hepatic integrin \u03b1v\u03b23 expression in non-alcoholic steatohepatitis (NASH) model mouse by 18F-FPP-RGD2 PET. EJNMMI Res. 2018;8:40.","journal-title":"EJNMMI Res"},{"key":"704_CR21","doi-asserted-by":"publisher","first-page":"e37506","DOI":"10.1371\/journal.pone.0037506","volume":"7","author":"N Guo","year":"2012","unstructured":"Guo N, Lang L, Li W, Kiesewetter DO, Gao H, Niu G, et al. Quantitative analysis and comparison study of [18F]AlF-NOTA-PRGD2, [18F]FPPRGD2 and [68Ga]Ga-NOTA-PRGD2 using a reference tissue model. PLoS ONE. 2012;7:e37506.","journal-title":"PLoS ONE"},{"key":"704_CR22","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s10456-013-9359-4","volume":"16","author":"JH Kim","year":"2013","unstructured":"Kim JH, Kim Y-H, Kim YJ, Yang BY, Jeong JM, Youn H, et al. Quantitative positron emission tomography imaging of angiogenesis in rats with forelimb ischemia using (68)Ga-NOTA-c(RGDyK). Angiogenesis. 2013;16:837\u201346.","journal-title":"Angiogenesis"},{"key":"704_CR23","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/jlcr.3111","volume":"56","author":"MB Haskali","year":"2013","unstructured":"Haskali MB, Roselt PD, Karas JA, Noonan W, Wichmann CW, Katsifis A, et al. One-step radiosynthesis of 4-nitrophenyl 2-[(18) F]fluoropropionate ([(18) F]NFP); improved preparation of radiolabeled peptides for PET imaging. J Label Comp Radiopharm. 2013;56:726\u201330.","journal-title":"J Label Comp Radiopharm"},{"key":"704_CR24","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.ejpb.2013.11.006","volume":"86","author":"ZH Jin","year":"2014","unstructured":"Jin ZH, Furukawa T, Sogawa C, Claron M, Aung W, Tsuji AB, et al. PET imaging and biodistribution analysis of the effects of succinylatedgelatin combined with l-lysine on renal uptake and retention of 64Cu-cyclam-RAFT-c(-RGDfK-)4 in vivo. Eur J Pharm Biopharm. 2014;86:478\u201386.","journal-title":"Eur J Pharm Biopharm"},{"key":"704_CR25","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1088\/0031-9155\/59\/3\/661","volume":"59","author":"M Bergeron","year":"2014","unstructured":"Bergeron M, Cadorette J, Tetrault M-A, Beaudoin J-F, Leroux J-D, Fontaine R, et al. Imaging performance of LabPET APD-based digital PET scanners for pre-clinical research. Phys Med Biol. 2014;59:661\u201378.","journal-title":"Phys Med Biol"},{"key":"704_CR26","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1038\/sj.jcbfm.9600493","volume":"27","author":"RB Innis","year":"2007","unstructured":"Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN, et al. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab. 2007;27:1533\u20139.","journal-title":"J Cereb Blood Flow Metab"},{"key":"704_CR27","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1109\/TAC.1974.1100705","volume":"19","author":"H Akaike","year":"1974","unstructured":"Akaike H. A new look at the statistical model identification. IEEE Trans Autom Control. 1974;19:716\u201323.","journal-title":"IEEE Trans Autom Control"},{"key":"704_CR28","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13550-017-0265-4","volume":"7","author":"IL Alves","year":"2017","unstructured":"Alves IL, V\u00e1llezGarc\u00eda D, Parente A, Doorduin J, Dierckx R, Marques da Silva AM, et al. Pharmacokinetic modeling of [11C]flumazenil kinetics in the rat brain. EJNMMI Res. 2017;7:17.","journal-title":"EJNMMI Res"},{"key":"704_CR29","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13550-017-0310-3","volume":"7","author":"U Bashir","year":"2017","unstructured":"Bashir U, Azad G, Siddique MM, Dhillon S, Patel N, Bassett P, et al. The effects of segmentation algorithms on the measurement of 18F-FDG PET texture parameters in non-small cell lung cancer. EJNMMI Res. 2017;7:60.","journal-title":"EJNMMI Res"},{"key":"704_CR30","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/iep.12008","volume":"94","author":"M Matsumoto","year":"2013","unstructured":"Matsumoto M, Hada N, Sakamaki Y, Uno A, Shiga T, Tanaka C, et al. An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis. Int J Exp Pathol. 2013;94:93\u2013103.","journal-title":"Int J Exp Pathol"},{"key":"704_CR31","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.3390\/nu9101072","volume":"9","author":"MA Van Herck","year":"2017","unstructured":"Van Herck MA, Vonghia L, Francque SM. Animal models of nonalcoholic fatty liver disease\u2014a starter\u2019s guide. Nutrients. 2017;9:1072.","journal-title":"Nutrients"},{"key":"704_CR32","first-page":"1097","volume":"11","author":"C Zhang","year":"2016","unstructured":"Zhang C, Liu H, Cui Y, Li X, Zhang Z, Zhang Y, et al. Molecular magnetic resonance imaging of activated hepatic stellate cells with ultrasmallsuperparamagnetic iron oxide targeting integrin \u03b1v\u03b23 for staging liver fibrosis in rat model. Int J Nanomed. 2016;11:1097\u2013108.","journal-title":"Int J Nanomed"},{"key":"704_CR33","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313\u201321.","journal-title":"Hepatology"},{"key":"704_CR34","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/hep.24467","volume":"54","author":"F Li","year":"2011","unstructured":"Li F, Song Z, Li Q, Wu J, Wang J, Xie C, et al. Molecular imaging of hepatic stellate cell activity by visualization of hepatic integrin \u03b1v\u03b23 expression with SPECT in rat. Hepatology. 2011;54:1020\u201330.","journal-title":"Hepatology"},{"key":"704_CR35","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1016\/j.celrep.2019.10.024","volume":"29","author":"R Dobie","year":"2019","unstructured":"Dobie R, Wilson-Kanamori JR, Henderson BEP, Smith JR, Matchett KP, Portman JR, et al. Single-cell transcriptomics uncovers zonation of function in the mesenchyme during liver fibrosis. Cell Rep. 2019;29:1832\u20131847.e8.","journal-title":"Cell Rep"},{"key":"704_CR36","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1007\/s00330-010-1988-z","volume":"21","author":"QB Wang","year":"2011","unstructured":"Wang QB, Han Y, Jiang TT, Chai WM, Chen KM, Liu BY, et al. MR Imaging of activated hepatic stellate cells in liver injured by CCl 4 of rats with integrin-targeted ultrasmallsuperparamagnetic iron oxide. Eur Radiol. 2011;21:1016\u201325.","journal-title":"Eur Radiol"},{"key":"704_CR37","doi-asserted-by":"publisher","first-page":"23996","DOI":"10.1074\/jbc.M311668200","volume":"279","author":"X Zhou","year":"2004","unstructured":"Zhou X, Murphy FR, Gehdu N, Zhang J, Iredale JP, Benyon RC. Engagement of \u03b1v\u03b23 integrin regulates proliferation and apoptosis of hepatic stellate cells. J Biol Chem. 2004;279:23996\u20134006.","journal-title":"J Biol Chem"},{"key":"704_CR38","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.bcp.2010.03.015","volume":"80","author":"XW Huang","year":"2010","unstructured":"Huang XW, Wang JY, Li F, Song ZJ, Xie C, Lu WY. Biochemical characterization of the binding of cyclic RGDyK to hepatic stellate cells. Biochem Pharmacol. 2010;80:136\u201343.","journal-title":"Biochem Pharmacol"},{"key":"704_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13550-015-0151-x","volume":"5","author":"D Li","year":"2015","unstructured":"Li D, He L, Guo H, Chen H, Shan H. Targeting activated hepatic stellate cells (aHSCs) for liver fibrosis imaging. EJNMMI Res. 2015;5:1\u201310.","journal-title":"EJNMMI Res"},{"key":"704_CR40","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-019-04586-z","author":"PT Lukey","year":"2019","unstructured":"Lukey PT, Coello C, Gunn R, Parker C, Wilson FJ, Saleem A, et al. Clinical quantification of the integrin \u03b1v\u03b26 by [18F]FB-A20FMDV2 positron emission tomography in healthy and fibrotic human lung (PETAL Study). Eur J Nucl Med Mol Imaging. 2019. https:\/\/doi.org\/10.1007\/s00259-019-04586-z.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"704_CR41","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1002\/hep.29646","volume":"67","author":"T Garc\u00eda-Lezana","year":"2018","unstructured":"Garc\u00eda-Lezana T, Raurell I, Bravo M, Torres-Arauz M, Salcedo MT, Santiago A, et al. Restoration of a healthy intestinal microbiota normalizes portal hypertension in a rat model of nonalcoholicsteatohepatitis. Hepatology. 2018;67:1485\u201398.","journal-title":"Hepatology"},{"key":"704_CR42","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1002\/hep.24805","volume":"55","author":"S Sethasine","year":"2012","unstructured":"Sethasine S, Jain D, Groszmann RJ, Garcia-Tsao G. Quantitative histological-hemodynamic correlations in cirrhosis. Hepatology. 2012;55:1146\u201353.","journal-title":"Hepatology"},{"key":"704_CR43","doi-asserted-by":"publisher","first-page":"15499","DOI":"10.3748\/wjg.v20.i42.15499","volume":"20","author":"S M\u00f8ller","year":"2014","unstructured":"M\u00f8ller S, Henriksen JH, Bendtsen F. Extrahepatic complications to cirrhosis and portal hypertension: Haemodynamic and homeostatic aspects. World J Gastroenterol. 2014;20:15499\u2013517.","journal-title":"World J Gastroenterol"},{"key":"704_CR44","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/j.dld.2017.06.011","volume":"49","author":"TM Busk","year":"2017","unstructured":"Busk TM, Bendtsen F, Henriksen JH, Fuglsang S, Clemmesen JO, Larsen FS, et al. Effects of transjugular intrahepatic portosystemic shunt (TIPS) on blood volume distribution in patients with cirrhosis. Dig Liver Dis. 2017;49:1353\u20139.","journal-title":"Dig Liver Dis"},{"key":"704_CR45","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1002\/hep.510230507","volume":"23","author":"P Van der Linden","year":"1996","unstructured":"Van der Linden P, Le Moine O, Ghysels M, Ortinez M, Deviere J. Pulmonary hypertension after transjugular intrahepatic portosystemic shunt: effects on right ventricular function. Hepatology. 1996;23:982\u20137.","journal-title":"Hepatology"},{"key":"704_CR46","first-page":"44","volume":"85","author":"S M\u00f8ller","year":"2009","unstructured":"M\u00f8ller S, Henriksen JH. Cardiovascular complications of cirrhosis. Postgrad Med J. 2009;85:44\u201354.","journal-title":"Postgrad Med J."}],"container-title":["EJNMMI Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-020-00704-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13550-020-00704-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-020-00704-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T21:20:38Z","timestamp":1633555238000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejnmmires.springeropen.com\/articles\/10.1186\/s13550-020-00704-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,7]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["704"],"URL":"https:\/\/doi.org\/10.1186\/s13550-020-00704-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-35927\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-35927\/v2","asserted-by":"object"}]},"ISSN":["2191-219X"],"issn-type":[{"value":"2191-219X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,7]]},"assertion":[{"value":"15 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The experimental protocols were reviewed and approved by the Institutional Animal Care and Use Committee of Shionogi & Co., Ltd. and Osaka University Graduate School of Medicine. All experiments were performed in accordance with the guidelines of Animal Care and Use Committee of Shionogi & Co., Ltd. and Osaka University Graduate School of Medicine.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"118"}}